Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVA-AMI
2006-002407-14Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in myocardial infarction (MI) comparing Eptifibatide with Abciximab (2 arms). Primary endpoint: Incidence of complete sum-ST resolution. Started Jul 2006; status: completed.
02
Drugs
eptifibatideabciximab
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-002407-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002407-14.